Yousef H, Alhajj M, Sharma S. Anatomy, Skin (Integument), Epidermis. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2021.
2. Schmidt A, Koch PJ. Desmosomes: just cell adhesion or is there more? Cell Adh Migr. 2007;1(1):28-32. DOI: 10.4161/cam.1.1.4204. Epub 2007 Jan 26. PMID: 19262094. PMCID: PMC2633677.
3. Delva E, Tucker DK, Kowalczyk AP. The desmosome. Cold Spring Harb Perspect Biol. 2009;1(2):a002543. DOI: 10.1101/cshperspect.a002543. PMID: 20066089. PMCID: PMC2742091.
4. Garrod D, Chidgey M. Desmosome structure, composition and function. Biochim Biophys Acta. 2008;1778(3):572-87. DOI: 10.1016/j.bbamem.2007.07.014. PMID: 17854763.
5. Borradori L, Sonnenberg A. Structure and Function of Hemidesmosomes: More Than Simple Adhesion Complexes. J Invest Dermatol. 1999;112(4):411-418. DOI: 10.1046/j.1523-1747.1999.00546.x. PMID: 10201522.
6. Harrison OJ, Brasch J, Lasso G, et al. Structural basis of adhesive binding by desmocollins and desmogleins. Proc Natl Acad Sci U S A. 2016;113(26):7160-7165. DOI: 10.1073/pnas.1606272113. PMID: 27298358. PMCID: PMC4932976.
7. Rose NR. Autoimmune Diseases. In: Quah SR, ed. International Encyclopedia of Public Health (Second Edition). Oxford: Academic Press; 2017:192-195.
8. Dinse G, Parks C, Weinberg C, et al. Increasing Prevalence of Antinuclear Antibodies in the United States. Arthritis Rheumatol. 2020;72(6):1026-1035. DOI: 10.1002/art.41214. PMID: 32266792. PMCID: PMC7255943.
9. Julian MK. Autoimmune disease: Cost-effective care. Nurs Manage. 2014;45(11):24-29; quiz 30. DOI: 10.1097/01.NUMA.0000455740.32485.9c. PMID: 25304753.
10. Egami S, Yamagami J, Amagai M. Autoimmune bullous skin diseases, pemphigus and pemphigoid. J Allergy Clin Immunol. 2020;145(4):1031-1047. DOI: 10.1016/j.jaci.2020.02.013. PMID: 32272980.
11. Kasperkiewicz M, Ellebrecht CT, Takahashi H, et al. Pemphigus. Nat Rev Dis Primers. 2017;3:17026. DOI: 10.1038/nrdp.2017.26. PMID: 28492232. PMCID: PMC5901732.
12. Amagai M, Tsunoda K, Zillikens D, Nagai T, Nishikawa T. The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile. J Am Acad Dermatol. 1999;40(2 Pt 1):167-170. DOI: 10.1016/s0190-9622(99)70183-0. PMID: 10025740.
13. Amagai M, Koch PJ, Nishikawa T, Stanley JR. Pemphigus vulgaris antigen (desmoglein 3) is localized in the lower epidermis, the site of blister formation in patients. J Invest Dermatol. 1996;106(2):351-355. DOI: 10.1111/1523-1747.ep12343081. PMID: 8601740.
14. Mahoney MG, Wang Z, Rothenberger K, Koch PJ, Amagai M, Stanley JR. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris. J Clin Invest. 1999;103(4):461-468. DOI: 10.1172/JCI5252. PMID: 10021453. PMCID: PMC408100.
15. Sinha AA, Sajda T. The Evolving Story of Autoantibodies in Pemphigus Vulgaris: Development of the “Super Compensation Hypothesis”. Front Med (Lausanne). 2018;5:218. DOI: 10.3389/fmed.2018.00218. PMID: 30155465. PMCID: PMC6102394.
16. Ahmed AR, Carrozzo M, Caux F, et al. Monopathogenic vs multipathogenic explanations of pemphigus pathophysiology. Exp Dermatol. 2016;25(11):839-846. DOI: 10.1111/exd.13106. PMID: 27305362.
17. Saschenbrecker S, Karl I, Komorowski L, et al. Serological Diagnosis of Autoimmune Bullous Skin Diseases. Front Immunol. 2019;10:1974. DOI: 10.3389/fimmu.2019.01974. PMID: 31552014. PMCID: PMC6736620.
18. Amber KT, Valdebran M, Grando SA. Non-Desmoglein Antibodies in Patients With Pemphigus Vulgaris. Front Immunol. 2018;9:1190. DOI: 10.3389/fimmu.2018.01190. PMID: 29915578. PMCID: PMC5994403.
19. Powell JG, Grover RK, Plunkett RW, Seiffert-Sinha K, Sinha AA. Evaluation of a Newly Available ELISA for Envoplakin Autoantibodies for the Diagnosis of Paraneoplastic Pemphigus. J Drugs Dermatol. 2015;14(10):1103-1106. PMID: 26461820.
20. Anhalt GJ. Paraneoplastic pemphigus. J Investig Dermatol Symp Proc. 2004;9(1):29-33. DOI: 10.1111/j.1087-0024.2004.00832.x. PMID: 14870982.
21. Poot AM, Diercks GF, Kramer D, et al. Laboratory diagnosis of paraneoplastic pemphigus. Br J Dermatol. 2013;169(5):1016-1024. DOI: 10.1111/bjd.12479. PMID: 23796242.
22. Hashimoto T, Teye K, Hashimoto K, et al. Clinical and Immunological Study of 30 Cases With Both IgG and IgA Anti-Keratinocyte Cell Surface Autoantibodies Toward the Definition of Intercellular IgG/IgA Dermatosis. Front Immunol. 2018;9:994. DOI: 10.3389/fimmu.2018.00994. PMID: 29867971. PMCID: PMC5950707.
23. Kridin K. Pemphigus group: overview, epidemiology, mortality, and comorbidities. Immunol Res. 2018;66(2):255-270. DOI: 10.1007/s12026-018-8986-7. PMID: 29479654.
24. Miyamoto D, Santi CG, Aoki V, Maruta CW. Bullous pemphigoid. An Bras Dermatol. 2019;94(2):133-146. DOI: 10.1590/abd1806-4841.20199007. PMID: 31090818. PMCID: PMC6486083.
25. Kridin K, Ludwig RJ. The Growing Incidence of Bullous Pemphigoid: Overview and Potential Explanations. Front Med (Lausanne). 2018;5:220. DOI: 10.3389/fmed.2018.00220. PMID: 30177969. PMCID: PMC6109638.
26. Kershenovich R, Hodak E, Mimouni D. Diagnosis and classification of pemphigus and bullous pemphigoid. Autoimmun Rev. 2014;13(4-5):477-481. DOI: 10.1016/j.autrev.2014.01.011. PMID: 24424192.
27. Ishiura N, Fujimoto M, Watanabe R, et al. Serum levels of IgE anti-BP180 and anti-BP230 autoantibodies in patients with bullous pemphigoid. J Dermatol Sci. 2008;49(2):153-161. DOI: 10.1016/j.jdermsci.2007.08.008. PMID: 17920818.
28. Yoshida M, Hamada T, Amagai M, et al. Enzyme-linked immunosorbent assay using bacterial recombinant proteins of human BP230 as a diagnostic tool for bullous pemphigoid. J Dermatol Sci. 2006;41(1):21-30. DOI: 10.1016/j.jdermsci.2005.11.002. PMID: 16364599.
29. Shimanovich I, Skrobek C, Rose C, et al. Pemphigoid gestationis with predominant involvement of oral mucous membranes and IgA autoantibodies targeting the C-terminus of BP180. J Am Acad Dermatol. 2002;47(5):780-784. DOI: 10.1067/mjd.2002.113677. PMID: 12399776.
30. Schumann H, Baetge J, Tasanen K, et al. The shed ectodomain of collagen XVII/BP180 is targeted by autoantibodies in different blistering skin diseases. Am J Pathol. 2000;156(2):685-695. DOI: 10.1016/S0002-9440(10)64772-4. PMID: 10666397. PMCID: PMC1850053.
31. Chiorean R, Danescu S, Virtic O, et al. Molecular diagnosis of anti-laminin 332 (epiligrin) mucous membrane pemphigoid. Orphanet J Rare Dis. 2018;13(1):111. DOI: 10.1186/s13023-018-0855-x. PMID: 29980216. PMCID: PMC6035451.
32. Kamaguchi M, Iwata H. The Diagnosis and Blistering Mechanisms of Mucous Membrane Pemphigoid. Front Immunol. 2019;10:34. DOI: 10.3389/fimmu.2019.00034. PMID: 30740099. PMCID: PMC6357922.
33. Egan CA, Lazarova Z, Darling TN, Yee C, Coté T, Yancey KB. Anti-epiligrin cicatricial pemphigoid and relative risk for cancer. Lancet. 2001;357(9271):1850-1851. DOI: 10.1016/S0140-6736(00)04971-0. PMID: 11410196.
34. Mehren CR, Gniadecki R. Epidermolysis bullosa acquisita: current diagnosis and therapy. Dermatol Reports. 2011;3(3):e38. DOI: 10.4081/dr.2011.e38. PMID: 25386290. PMCID: PMC4211502.
35. Kridin K, Kneiber D, Kowalski EH, Valdebran M, Amber KT. Epidermolysis bullosa acquisita: A comprehensive review. Autoimmunity Reviews. 2019;18(8):786-795. DOI: 10.1016/j.autrev.2019.06.007. PMID: 31181325.
36. Antiga E, Caproni M. The diagnosis and treatment of dermatitis herpetiformis. Clin Cosmet Investig Dermatol. 2015;8:257-265. DOI: 10.2147/CCID.S69127. PMID: 25999753. PMCID: PMC4435051.
37. Salmi TT. Dermatitis herpetiformis. Clin Exp Dermatol. 2019;44(7):728-731. DOI: 10.1111/ced.13992. PMID: 31093998.
38. Witte M, Zillikens D, Schmidt E. Diagnosis of Autoimmune Blistering Diseases. Front Med (Lausanne). 2018;5:296. DOI: 10.3389/fmed.2018.00296. PMID: 30450358. PMCID: PMC6224342.
39. Murrell DF, Peña S, Joly P, et al. Diagnosis and management of pemphigus: Recommendations of an international panel of experts. J Am Acad Dermatol. 2020;82(3):575-585.e1. DOI: 10.1016/j.jaad.2018.02.021. PMID: 29438767. PMCID: PMC7313440.
40. Shetty VM, Subramaniam K, Rao R. Utility of immunofluorescence in dermatology. Indian Dermatol Online J. 2017;8(1):1-8. DOI: 10.4103/2229-5178.198774. PMID: 28217464. PMCID: PMC5297263.
41. Feibelman C, Stolzner G, Provost TT. Pemphigus Vulgaris: Superior Sensitivity of Monkey Esophagus in the Determination of Pemphigus Antibody. Arch Dermatol. 1981;117(9):561-562. DOI: 10.1001/archderm.117.9.561. PMID: 7027966.
42. Ghohestani RF, Nicolas JF, Rousselle P, Claudy AL. Diagnostic value of indirect immunofluorescence on sodium chloride-split skin in differential diagnosis of subepidermal autoimmune bullous dermatoses. Arch Dermatol. 1997;133(9):1102-1107. PMID: 9301587.
43. Liu AY, Valenzuela R, Helm TN, Camisa C, Melton AL, Bergfeld WF. Indirect immunofluorescence on rat bladder transitional epithelium: a test with high specificity for paraneoplastic pemphigus. J Am Acad Dermatol. 1993;28(5 Pt 1):696-699. DOI: 10.1016/0190-9622(93)70095-b. PMID: 7684408.
44. Wolf J, Jahnke A, Fechner K, et al. Primate liver tissue as an alternative substrate for endomysium antibody immunofluorescence testing in diagnostics of paediatric coeliac disease. Clin Chim Acta. 2016;460:72-77. DOI: 10.1016/j.cca.2016.06.023. PMID: 27346479.
45. Chanprapaph K, Ounsakul V, Pruettivorawongse D, Thadanipon K. Anti-BP180 and anti-BP230 enzyme-linked immunosorbent assays for diagnosis and disease activity tracking of bullous pemphigoid: A prospective cohort study. Asian Pac J Allergy Immunol. 2019; 39(4):272-278. DOI: 10.12932/AP-231118-0446. PMID: 31175713.
46. Delavarian Z, Layegh P, Pakfetrat A, Zarghi N, Khorashadizadeh M, Ghazi A. Evaluation of desmoglein 1 and 3 autoantibodies in pemphigus vulgaris: correlation with disease severity. J Clin Exp Dent. 2020;12(5):e440-e445. DOI: 10.4317/jced.56289. PMID: 32509225. PMCID: PMC7263783.
47. Koga H, Teye K, Yamashita K, Ishii N, Tsuruta D, Nakama T. Detection of anti-type VII collagen IgE antibodies in epidermolysis bullosa acquisita. Br J Dermatol. 2019;180(5):1107-1113. DOI: 10.1111/bjd.17310. PMID: 30311191.
48. Kim JH, Kim YH, Kim S, et al. Serum levels of anti-type VII collagen antibodies detected by enzyme-linked immunosorbent assay in patients with epidermolysis bullosa acquisita are correlated with the severity of skin lesions. J Eur Acad Dermatol Venereol. 2013;27(2):e224-e230. DOI: 10.1111/j.1468-3083.2012.04617.x. PMID: 22731917.
49. Mutasim DF. Therapy of autoimmune bullous diseases. Ther Clin Risk Manag. 2007;3(1):29-40. DOI: 10.2147/tcrm.2007.3.1.29. PMID: 18360613. PMCID: PMC1936286.
50. Alaeen H, Toosi R, Mahmoudi H, et al. Short-term clinical and serological follow-up with conventional and conformational anti-desmoglein antibodies in treatment-naïve and previously treated patients with pemphigus vulgaris after receiving rituximab. Int J Womens Dermatol. 2019;5(5):372-377. DOI: 10.1016/j.ijwd.2019.05.008. PMID: 31909160. PMCID: PMC6938821.